|
ACER3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.66199999999517E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.423100E-04 |
| Normal-vs-Stage2 |
3.239600E-03 |
| Normal-vs-Stage3 |
3.214600E-04 |
| Normal-vs-Stage4 |
8.95779999954271E-07 |
| Stage1-vs-Stage2 |
8.226800E-01 |
| Stage1-vs-Stage3 |
7.404800E-01 |
| Stage1-vs-Stage4 |
5.836300E-02 |
| Stage2-vs-Stage3 |
6.517600E-01 |
| Stage2-vs-Stage4 |
6.261500E-02 |
| Stage3-vs-Stage4 |
1.254750E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.647100E-04 |
| Normal-vs-AfricanAmerican |
4.396600E-03 |
| Normal-vs-Asian |
2.0332999994821E-07 |
| Caucasian-vs-AfricanAmerican |
7.740000E-01 |
| Caucasian-vs-Asian |
1.200080E-02 |
| AfricanAmerican-vs-Asian |
2.000600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.957600E-04 |
| Normal-vs-Female |
1.94179999999378E-05 |
| Male-vs-Female |
5.814000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.383400E-04 |
| Normal-vs-Age(41-60Yrs) |
6.31060000033656E-07 |
| Normal-vs-Age(61-80Yrs) |
3.804300E-03 |
| Normal-vs-Age(81-100Yrs) |
4.050100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.011000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.410600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.501600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.474180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.726600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.380000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.222200E-01 |
| Classical-VS-Follicular |
7.678600E-01 |
| Classical-VS-Other |
2.946300E-02 |
| Classical-VS-Normal |
3.360000E-04 |
| Tall-VS-Follicular |
4.850200E-01 |
| Tall-VS-Other |
2.455000E-01 |
| Tall-VS-Normal |
1.099930E-03 |
| Follicular-VS-Other |
4.875900E-02 |
| Follicular-VS-Normal |
1.075160E-03 |
| Other-VS-Normal |
2.122000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.780280E-04 |
| Normal-vs-N1 |
3.74240000100556E-08 |
| N0-vs-N1 |
7.899100E-03 |
|
|
